Adaptive Biotechnologies Corporation logo
Adaptive Biotechnologies Corporation ADPT
$ 5.19 -2.35%

Quarterly report 2024-Q2
added 08-01-2024

report update icon

Adaptive Biotechnologies Corporation Financial Ratios 2011-2024 | ADPT

Annual Financial Ratios Adaptive Biotechnologies Corporation

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-2.6 -6.1 -9.8 -50.8 -31.1 - - - - - - - -

P/S

3.5 6.6 13.1 75.4 25.1 - - - - - - - -

EPS

-1.6 -1.4 -1.5 -1.1 -1.0 -3.7 -3.5 - - - - - -

EV (Enterprise Value)

884 M 1.53 B 2.21 B 7.67 B 2.38 B 591 M 587 M - - - - - -

EBITDA per Share

-1.43 -1.27 -1.4 -1.11 -1.11 - - - - - - - -

EV/EBITDA

-10.9 -49.5 -26.5 - - - - - - - -

PEG

- 5.25 0.24 - - - - - - - -

P/B

1.9 2.6 3.4 10.0 3.7 - - - - - - - -

P/CF

-3.8 -6.7 -10.5 -49.6 11.0 - - - - - - - -

ROE %

-73.04 -43.13 -34.31 -19.67 -12.01 - - - - - - - -

ROA %

-34.07 -23.37 -22.45 -13.10 -7.52 - - - - - - - -

ROCE %

-73.62 -43.13 -34.59 -20.56 -9.40 - - - - - - - -

Current Ratio

1.9 2.2 2.9 3.0 7.8 - - - - - - - -

DSO

83.6 56.6 32.5 42.2 54.4 - - - - - - - -

DIO

69.8 106.3 123.4 187.4 148.6 - - - - - - - -

DPO

38.2 35.9 24.2 62.3 73.0 - - - - - - - -

Operating Cycle

153.4 162.8 155.8 229.5 203.0 - - - - - - - -

Cash Conversion Cycle

115.3 127.0 131.6 167.2 130.0 - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Adaptive Biotechnologies Corporation

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.31 -0.33 - -0.35 -0.33 -0.4 - -0.32 -0.37 -0.44 - -0.4 -0.35 -0.29 - -0.27 -0.26 -0.25 - -0.11 -1.23 -1.45 - -0.66 -1.01 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

-0.29 -0.3 - -0.35 -0.29 -0.36 - -0.31 -0.37 -0.41 - -0.34 -0.35 -0.28 - -0.24 -0.27 -0.26 - -0.11 -1 -1.45 - -0.48 -0.91 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

-64.22 -57.17 -39.59 -48.87 -44.25 -42.22 -30.66 -39.24 -38.54 -36.58 -22.26 -27.20 -23.56 -19.99 -13.68 -16.12 -13.62 -11.85 -8.40 -5.19 0.46 8.05 8.05 8.05 4.84 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

-29.58 -27.93 -20.55 -25.67 -23.79 -24.84 -19.74 -25.37 -18.57 -23.99 -14.84 -18.13 -15.79 -13.37 -9.11 -10.63 -8.87 -7.59 -5.26 -7.75 -8.72 -10.76 -6.25 -6.25 -3.76 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROCE %

-65.50 -57.99 -39.65 -48.97 -44.19 -42.25 -30.84 -39.49 -38.82 -35.87 -21.51 -26.50 -22.84 -20.62 -14.61 -17.77 -15.95 -13.80 -9.49 -5.94 0.77 8.75 8.71 8.71 5.16 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

1.7 1.8 1.9 2.0 2.1 2.1 2.2 2.2 - 2.8 2.9 2.9 3.0 3.1 3.0 3.0 3.0 3.0 2.7 2.7 2.7 2.7 11.1 11.1 11.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

82.0 87.2 - 75.5 58.3 86.1 - 25.3 23.5 47.2 - 36.2 40.2 35.4 - 34.9 43.7 49.6 - 44.4 52.2 63.0 - 25.5 19.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

62.6 70.1 - 90.7 98.9 83.8 - 53.1 72.5 139.3 - 118.5 152.7 143.8 - 212.0 261.2 197.5 - 147.8 144.3 154.7 - 133.4 70.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

52.0 50.3 - 32.2 39.5 35.2 - 12.7 20.6 32.0 - 46.1 47.9 38.5 - 48.8 60.1 65.7 - 72.5 70.9 57.1 - 30.5 16.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

144.6 157.3 - 166.2 157.2 169.9 - 78.4 96.0 186.4 - 154.7 192.9 179.2 - 246.9 304.9 247.1 - 192.1 196.6 217.6 - 159.0 89.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

92.6 107.0 - 134.0 117.8 134.7 - 65.7 75.5 154.4 - 108.5 145.1 140.6 - 198.1 244.8 181.4 - 119.6 125.7 160.5 - 128.4 73.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency